Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa

Journal:
Clinical Infectious Diseases
Published:
DOI:
10.1093/cid/ciaf495
Affiliations:
9
Authors:
14
Go to article
Institutions Authors Share
Foundation for Innovative New Diagnostics (FIND), Switzerland
5.000000
 0.36
Amsterdam UMC, Netherlands
2.333333
 0.17
University of Ottawa (uOttawa), Canada
2.000000
 0.14
University of the Witwatersrand, Johannesburg (Wits University), South Africa
1.333333
 0.10
National Health Laboratory Service (NHLS), South Africa
1.000000
 0.07
UC San Diego Health Sciences, United States of America (USA)
1.000000
 0.07
Gates Foundation, United States of America (USA)
1.000000
 0.07
Boston University (BU), United States of America (USA)
0.333333
 0.02
Interested in Medical Biotechnology?